Literature DB >> 2231070

Nicotine dependence: a preventable risk factor for other diseases.

C Cohen1, J E Henningfield.   

Abstract

Nicotine meets all critical criteria for an addictive drug. Furthermore, there is no evidence that there would be widespread compulsive use of tobacco without nicotine. These findings have led to consideration of the cigarette as a contaminated vehicle for an addictive drug (nicotine). Nevertheless, nicotine itself may also be used therapeutically to reduce exposure to carcinogens and other tobacco toxins. Nicotine replacement is a useful adjunct in treating tobacco dependence. For example, nicotine replacement in the form of a polacrilex resin (chewing gum) can alleviate physically based signs and symptoms of tobacco abstinence. The fact that this form of nicotine replacement is not attractive to non-users of tobacco has opened the door to the use of nicotine in a therapeutic modality, permitting hope of eliminating tobacco dependence.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2231070     DOI: 10.1007/bf02600847

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  11 in total

Review 1.  Involvement of tobacco in alcoholism and illicit drug use.

Authors:  J E Henningfield; R Clayton; W Pollin
Journal:  Br J Addict       Date:  1990-02

Review 2.  The reemergence of smokeless tobacco.

Authors:  G N Connolly; D M Winn; S S Hecht; J E Henningfield; B Walker; D Hoffmann
Journal:  N Engl J Med       Date:  1986-04-17       Impact factor: 91.245

Review 3.  Neuroregulators and the reinforcement of smoking: towards a biobehavioral explanation.

Authors:  O F Pomerleau; C S Pomerleau
Journal:  Neurosci Biobehav Rev       Date:  1984       Impact factor: 8.989

4.  Measurement of adolescent smoking behavior: rationale and methods.

Authors:  T F Pechacek; D M Murray; R V Luepker; M B Mittelmark; C A Johnson; J M Shutz
Journal:  J Behav Med       Date:  1984-03

Review 5.  Pharmacologic basis and treatment of cigarette smoking.

Authors:  J E Henningfield
Journal:  J Clin Psychiatry       Date:  1984-12       Impact factor: 4.384

6.  Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine.

Authors:  J E Henningfield; K Miyasato; D R Jasinski
Journal:  J Pharmacol Exp Ther       Date:  1985-07       Impact factor: 4.030

7.  Central sites and mechanisms of action of nicotine.

Authors:  J A Rosecrans; L T Meltzer
Journal:  Neurosci Biobehav Rev       Date:  1981       Impact factor: 8.989

8.  Smokers of low-yield cigarettes do not consume less nicotine.

Authors:  N L Benowitz; S M Hall; R I Herning; P Jacob; R T Jones; A L Osman
Journal:  N Engl J Med       Date:  1983-07-21       Impact factor: 91.245

9.  Nicotine as a reinforcer in human subjects and laboratory animals.

Authors:  J E Henningfield; S R Goldberg
Journal:  Pharmacol Biochem Behav       Date:  1983-12       Impact factor: 3.533

10.  Signs and symptoms of tobacco withdrawal.

Authors:  J R Hughes; D Hatsukami
Journal:  Arch Gen Psychiatry       Date:  1986-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.